NIOX Group (NIOX Group) Institutional Ownership : 8.57% (As of Jun. 06, 2024)

View and export this data going back to 2014. Start your Free Trial

What is NIOX Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NIOX Group's institutional ownership is 8.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NIOX Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NIOX Group's Float Percentage Of Total Shares Outstanding is 0.00%.

NIOX Group Institutional Ownership Historical Data

The historical data trend for NIOX Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NIOX Group Institutional Ownership Chart

NIOX Group Historical Data

The historical data trend for NIOX Group can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	7.10	7.17	7.46	7.98	8.28	8.48	8.34	8.64	8.60	8.57

NIOX Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

NIOX Group (NIOX Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NIOX Group PLC (OTCPK:CSSPF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

NIOX:UK 82C:Germany

Address

Edmund Halley Road, Hayakawa Building, The Oxford Science Park, Oxford, GBR, OX4 4GB

Website

https://investors.niox.com

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.